{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:00:50Z","timestamp":1793134850535,"version":"4.5.0"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T00:00:00Z","timestamp":1463011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01-AI068641"],"award-info":[{"award-number":["U01-AI068641"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Allergy and Infectious Diseases (US)","award":["U01-AI046362"],"award-info":[{"award-number":["U01-AI046362"]}]},{"name":"National Institute of Allergy and Infectious Diseases (US)","award":["U01-AI042170"],"award-info":[{"award-number":["U01-AI042170"]}]},{"name":"National Institute of Allergy and Infectious Diseases (US)","award":["U01-AI46957"],"award-info":[{"award-number":["U01-AI46957"]}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["3U 01-AI068641-0451"],"award-info":[{"award-number":["3U 01-AI068641-0451"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Allergy and Infectious Diseases (US)","award":["3U01-AI06841-0551"],"award-info":[{"award-number":["3U01-AI06841-0551"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0155100","type":"journal-article","created":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T18:00:07Z","timestamp":1463076007000},"page":"e0155100","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":193,"title":["Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy"],"prefix":"10.1371","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4275-7880","authenticated-orcid":true,"given":"Birgit","family":"Grund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason V","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Deeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Wolfson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Wentworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Cozzi-Lepri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin J.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens D.","family":"Lundgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Neaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"INSIGHT SMART\/ESPRIT\/SILCAAT Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,5,12]]},"reference":[{"issue":"12","key":"ref1","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1097\/QAD.0b013e32833b1b26","article-title":"Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients","volume":"24","author":"AC Achhra","year":"2010","journal-title":"AIDS"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/652283","article-title":"Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996\u20132006: collaborative analysis of 13 HIV cohort studies","volume":"50","year":"2010","journal-title":"Clinical Infectious Diseases"},{"issue":"9","key":"ref3","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection","volume":"373","author":"JD Lundgren","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/QAD.0b013e32835cb766","article-title":"CD4 cell count and viral load-specific rates of AIDS, non-AIDS and deaths according to current antiretroviral use","volume":"27","author":"A Mocroft","year":"2013","journal-title":"AIDS"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"e44454","DOI":"10.1371\/journal.pone.0044454","article-title":"Inflammation, coagulation and cardiovascular disease in HIV-infected individuals","volume":"7","author":"DA Duprez","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.000844","article-title":"Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation","volume":"3","author":"AD Nordell","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/QAI.0b013e3181a9992c","article-title":"Association of C-reactive protein and HIV infection with acute myocardial infarction","volume":"51","author":"VA Triant","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"ref8","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/QAD.0b013e32835f6b0c","article-title":"Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers","volume":"27","author":"AH Borges","year":"2013","journal-title":"AIDS"},{"issue":"13","key":"ref9","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1097\/QAD.0b013e328355d659","article-title":"Reclassification of risk of death with the knowledge of D-dimer in a cohort of treated HIV-infected individuals","volume":"26","author":"AC Achhra","year":"2012","journal-title":"AIDS"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1371\/journal.pmed.0050203","article-title":"Inflammatory and coagulation biomarkers and mortality in patients with HIV infection","volume":"5","author":"LH Kuller","year":"2008","journal-title":"PLoS Med"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/QAI.0b013e3181e66216","article-title":"Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort","volume":"55","author":"PC Tien","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/QAI.0b013e3181f7f61a","article-title":"Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection","volume":"56","author":"JV Baker","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1086\/652749","article-title":"Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection","volume":"201","author":"J Neuhaus","year":"2010","journal-title":"The Journal of Infectious Diseases"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1371\/journal.pmed.0050078","article-title":"Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review","volume":"5","author":"J Danesh","year":"2008","journal-title":"PLoS Med"},{"issue":"19","key":"ref15","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1161\/01.CIR.103.19.2323","article-title":"Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis","volume":"103","author":"J Danesh","year":"2001","journal-title":"Circulation"},{"issue":"9709","key":"ref16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"S Kaptoge","year":"2010","journal-title":"Lancet"},{"issue":"25","key":"ref17","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa040967","article-title":"Inflammatory markers and the risk of coronary heart disease in men and women","volume":"351","author":"JK Pai","year":"2004","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1160\/TH14-04-0297","article-title":"Elevated levels of D-dimers increase the risk of ischaemic and haemorrhagic stroke. Findings from the EPICOR Study","volume":"112","author":"A Di Castelnuovo","year":"2014","journal-title":"Thrombosis and Haemostasis"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1161\/01.ATV.0000079512.66448.1D","article-title":"C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study","volume":"23","author":"G Luc","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"15","key":"ref20","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/01.CIR.101.15.1767","article-title":"Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men","volume":"101","author":"PM Ridker","year":"2000","journal-title":"Circulation"},{"issue":"20","key":"ref21","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1161\/CIRCULATIONAHA.105.557132","article-title":"Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study","volume":"112","author":"A Smith","year":"2005","journal-title":"Circulation"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/oxfordjournals.aje.a008963","article-title":"Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial","volume":"144","author":"LH Kuller","year":"1996","journal-title":"American Journal of Epidemiology"},{"issue":"13","key":"ref23","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1200\/JCO.2008.19.8440","article-title":"Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer","volume":"27","author":"KH Allin","year":"2009","journal-title":"Journal of Clinical Oncology: official journal of the American Society of Clinical Oncology"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1158\/1055-9965.EPI-05-0316","article-title":"Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort","volume":"14","author":"D Il'yasova","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"11394","DOI":"10.1038\/srep11394","article-title":"Circulating interleukin-6 and cancer: A meta-analysis using Mendelian randomization","volume":"5","author":"G Tian","year":"2015","journal-title":"Sci Rep"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1053\/j.ajkd.2008.10.044","article-title":"Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study","volume":"53","author":"LD Bash","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"ref27","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.3324\/haematol.2012.083410","article-title":"Association of D-dimer levels with all-cause mortality in a healthy adult population: findings from the MOLI-SANI study","volume":"98","author":"A Di Castelnuovo","year":"2013","journal-title":"Haematologica"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/ajh.21429","article-title":"Associations of factor VIII(c), D-dimer, and plasmin-antiplasmin with incident cardiovascular disease and all-cause mortality","volume":"84","author":"AR Folsom","year":"2009","journal-title":"Am J Hematol"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0002-9343(99)00066-2","article-title":"Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly","volume":"106","author":"TB Harris","year":"1999","journal-title":"Am J Med"},{"issue":"8","key":"ref30","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1097\/QAD.0b013e32835ecb8b","article-title":"Persistent immune activation in chronic HIV infection: do any interventions work?","volume":"27","author":"R Rajasuriar","year":"2013","journal-title":"AIDS"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/QAI.0b013e31822ccfcc","article-title":"Disease-modifying therapeutic concepts for HIV in the era of highly active antiretroviral therapy","volume":"58","author":"SL Butler","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"22","key":"ref32","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+ count-guided interruption of antiretroviral treatment","volume":"355","author":"WM El-Sadr","year":"2006","journal-title":"N Engl J Med"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.7326\/0003-4819-149-5-200809020-00003","article-title":"Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy\u2014a randomized trial","volume":"149","author":"W El-Sadr","year":"2008","journal-title":"Annals of Internal Medicine"},{"issue":"16","key":"ref34","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJMoa0903175","article-title":"Interleukin-2 Therapy in Patients with HIV Infection","volume":"361","author":"D Abrams","year":"2009","journal-title":"New England Journal of Medicine"},{"key":"ref35","unstructured":"CIOMS Working Group. Introductiory Guide for Standardised MedDRA Queries (SMQs) Version 12.0. In: International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), editor. 2009."},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/EDE.0b013e31821b5332","article-title":"The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology","volume":"22","author":"JD Kowalska","year":"2011","journal-title":"Epidemiology"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/oxfordjournals.aje.a009801","article-title":"Analytical and biologic variability in measures of hemostasis, fibrinolysis, and inflammation: assessment and implications for epidemiology","volume":"149","author":"PA Sakkinen","year":"1999","journal-title":"Am J Epidemiol"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/0049124104268644","article-title":"Multimodel inference\u2014understanding AIC and BIC in model selection","volume":"33","author":"K Burnham","year":"2004","journal-title":"Sociological Methods & Research"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.2307\/2532247","article-title":"Regression dilution in the proportional hazards model","volume":"49","author":"MD Hughes","year":"1993","journal-title":"Biometrics"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1047-2797(97)00107-5","article-title":"Adjustment for regression dilution in epidemiological regression analyses","volume":"8","author":"MW Knuiman","year":"1998","journal-title":"Ann Epidemiol"},{"key":"ref41","article-title":"R: A language and environment for statistical computing","year":"2014"},{"issue":"Suppl 1","key":"ref42","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1538-7836.2009.03404.x","article-title":"Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)","volume":"7","author":"PM Ridker","year":"2009","journal-title":"J Thromb Haemost"},{"key":"ref43","unstructured":"National Institute of Allergy and Infectious Diseases (NIAID). NIH Launches Largest Clinical Trial Focused on HIV-Related Cardiovascular Disease. NIH News 2015 [cited 2015 26 September]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.niaid.nih.gov\/news\/newsreleases\/2015\/Pages\/REPRIEVE.aspx\" xlink:type=\"simple\">http:\/\/www.niaid.nih.gov\/news\/newsreleases\/2015\/Pages\/REPRIEVE.aspx<\/ext-link>."},{"issue":"9","key":"ref44","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/QAD.0b013e32835f6b0c","article-title":"Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers","volume":"27","author":"AH Borges","year":"2013","journal-title":"AIDS"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMra1011170","article-title":"The coagulopathy of chronic liver disease","volume":"365","author":"A Tripodi","year":"2011","journal-title":"N Engl J Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0155100","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T07:04:11Z","timestamp":1589007851000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0155100"}},"subtitle":[],"editor":[{"given":"Esaki M.","family":"Shankar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,5,12]]},"references-count":45,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0155100","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,12]]}}}